Nanil Therapeutics Inc.
1 known investors
Nanil Therapeutics develops AI-native discovery platforms for CNS-targeting therapeutic modalities, focusing on RNA-based approaches for neurodegenerative diseases like tauopathies and Alzheimer's. The company integrates quantum computing, generative AI, and molecular modeling to design and optimize mRNA therapeutics and identify blood-brain barrier-penetrant biologics.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Nanil Therapeutics Inc. do?
- Nanil Therapeutics develops AI-native discovery platforms for CNS-targeting therapeutic modalities, focusing on RNA-based approaches for neurodegenerative diseases like tauopathies and Alzheimer's. The company integrates quantum computing, generative AI, and molecular modeling to design and optimize mRNA therapeutics and identify blood-brain barrier-penetrant biologics.
- Who are Nanil Therapeutics Inc.'s investors?
- Nanil Therapeutics Inc.'s investors include CABHI Ventures.